Introduction
Approximately 70% of people with epilepsy have the potential to be seizure free with accurate diagnosis and optimal treatment. 1 However only 52% are seizure free in the UK 2 demonstrating an 18% treatment gap. 3 Appropriate diagnosis and treatment helps to minimize social and financial deprivation, stigmatization, misunderstanding, and promotes independence and employability. 4 Once diagnosed with epilepsy, management involves the prescription of long-term treatment with anti-epilepsy medication and regular monitoring. The authors suggest that appropriate and early treatment can reduce the number of General Practitioner (GP) consultations and reduce emergency admissions to secondary care due to seizures or seizure related injury.
The National Health Service Plan 5 suggests that nurses can improve patient care by undertaking a wider range of clinical tasks including making and receiving direct referrals, admitting and discharging patients, ordering investigations and diagnostic tests, running clinics and prescribing drugs. Nurse prescribing in the UK was introduced in 1992 with 'The Medicinal Products. Prescribing by Nurses Act' (1992) that permitted nurses to prescribe a limited range of drugs that included wound dressings and ointments. The Crown Report 6 had previously identified that nurse prescribers would improve patient care through improved use of nurse time.
To become a non-medical prescriber the nurse has to have worked in the field in which they intend to prescribe for at least 12 months and undertake a designated prescribing course. Once passed the prescribing qualification enables the nurse to prescribe within his/her own level of professional competence and expertise. Those who do so have to demonstrate the appropriate legal and professional requirements. Courses are approved by the Nursing and Midwifery Council (NMC) and teach the principles of safe prescribing practice. The course is between 3 and 6 months long Recent advances in legislation have enabled nurses in the United Kingdom (UK) to become Nurse Independent and Supplementary Prescribers (NISP). The NISP can assess, diagnose and independently prescribe any licensed medicine within their area of competence. This change has meant the number of nurse prescribers in disease specific areas has increased. This study set out to assess the number of Epilepsy Specialist Nurses (ESNs) prescribing and the context in which they do so.
A draft questionnaire was developed and piloted with 10 ESNs. Minor changes to improve data collection were made. In April 2009 all known ESNs were invited via letter to complete the questionnaire. One month later a follow up reminder was mailed to all ESNs to encourage participation. Data was analyzed using percentages and cross tabulation.
Completed questionnaires were returned by 29 nurse prescribers. Twenty ESNs were working as independent nurse prescribers, 6 as supplementary nurse prescribers and 3 as both. Prescribing practice demonstrated that 21 (72%) signed prescriptions, 28 (97%) made recommendations to other prescribers, 14 (48%) prescribed or amended ward/in patient drug prescriptions and 10 (34%) used clinical management plans. The medications prescribed by ESNs included anti-epilepsy medication, folic acid, vitamin K, anti-depressants, steroids, rescue medication and the contraceptive pill. Most ESNs wrote a prescription for a new drug at least once a week whilst most nurses titrated medication daily.
Nurse prescribers held higher academic qualifications and had worked in the field of epilepsy for years. Epilepsy specialist nurse prescribing enabled a holistic approach to patient care. This paper identified the need for ESNs to update annually and audit their prescribing practice.
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and includes 12 days of learning in practice with a designated medical practitioner. Once the course is completed the qualification has to be registered with the NMC before the nurse can lawfully prescribe. Individual employers may set local requirements such as an individual drug formulary for each individual nurse prescriber. A new form of prescribing 'supplementary prescribing' for allied health professionals was suggested in 1999. 7 Supplementary prescribing is 'a voluntary prescribing partnership between an independent prescriber (doctor) and a supplementary prescriber (nurse or pharmacist, etc.) to implement a patient specific clinical management plan (CMP)'. 8 'A CMP is an agreed, defined plan of treatment for a named patient which sets the legal boundaries of the medication and the parameters of prescribing responsibility for the supplementary prescriber'. 9 Supplementary prescribing allows the nurse to prescribe all general sales list items, all prescription only medicines, all controlled drugs, off label medicines and unlicensed drugs following diagnosis by the doctor. 9 The law changed again in May 2006 to allow nurses to independently prescribe. A Nurse Independent Prescriber (NISP) can assess, diagnose and independently prescribe any licensed medicine within the nurse's area of competence, 10 including controlled drugs and off label medications. In December 2009 the law was amended once again to include unlicensed medications.
11
A recent paper 12 identifies that between 2% and 3% of nurses in the UK are qualified to prescribe medicines independently. Since allowing nurses to assess, diagnose and independently prescribe, the number of nurses prescribing in disease specific areas has increased and encompasses specialist and consultant nurses, perhaps reflecting the relevance of this change to advanced nurse practice. This finding is supported by our study that demonstrates 18% of all ESNs are nurse prescribers. However there is evidence that nurses do not prescribe, or prescribe infrequently after gaining their prescribing qualification. 13, 14 Reasons identified in our research include lack of access to prescribing budgets, the inability to prescribe immediately on qualifying which can lead to loss of confidence, lack of access to medical notes, peer support and clinical supervision. It is imperative that independent nurse prescribers are safe, update regularly, and their practice is beneficial to patient care. This paper will review the role of epilepsy specialist nurses (ESNs) as prescribers and the problems that ESNs have encountered in their prescribing practice.
Methodology
The research group developed a draft questionnaire that was piloted with 10 ESNs and feedback was obtained on its design and questions. Comments enabled the researchers to make some minor changes to formulate the final draft. In April 2009 all known ESNs were invited to participate via letter. The completed questionnaire was returned. One month later a follow up reminder was mailed to all ESNs to encourage participation.
The data was analyzed using percentages and cross tabulation. Data analyzed was sub-divided into those that had a prescribing qualification and those that had not. The results presented in this paper are based on 29 epilepsy specialist nurse prescribers who held the prescribing qualification.
Results
Postal questionnaires were sent to 218 nurses. There were 120 replies (55%). Twenty-nine ESNs had completed the prescribing course. Of these, 20 ESNs were working as independent nurse prescribers, 6 as supplementary nurse prescribers and 3 as both. The results presented are based on these 29 (100%) nurse prescribers.
The respondents were epilepsy specialist nurses or senior nurses with a significant epilepsy role component. Twelve (42%) worked in the field of adults with epilepsy, 7 (24%) in paediatrics, and 10 (34%) within learning disabilities. Seven ESNs worked with more than one group of patients. The majority of respondents had been in their current post over 10 years with 5 years or longer working in the field of epilepsy (Fig. 1) .
The respondents worked across services with 19 (66%) employed in secondary care services, 2 (7%) in primary care services and 4 (14%) employed across both primary and secondary care. Three (10%) worked in tertiary services and 1 (3%) in the private sector. The level of academic qualification ranged from registered nurse (RN) qualification to masters degree (2 RN (7%), 5 epilepsy diploma (17%), 13 1st degree (45%), 9 masters degree (31%)). Nurse prescribing practice demonstrated that 21 (72%) signed prescriptions, 28 (97%) made recommendations to alter medication to other prescribers, 14 (48%) prescribed or amended ward/in-patient drug prescriptions and 10 (34%) used clinical management plans.
A range of drugs were prescribed or recommended by ESNs and included anti-epilepsy medication, folic acid, vitamin K, antidepressants, steroids, rescue medication, anti-psychotic drugs and the contraceptive pill. ESNs would then write to the GP (28 (97%)) and/or the patient (24 (83%)) and use other internal documentation to record drug changes (Fig. 2) .
Only 15 (52%) of the nurse prescribers were involved with inpatient prescribing. Of these 12 (41%) would alter drug charts and/or 16 (55%) would speak directly to the patient's doctor to recommend medication change. The findings from this study found that 22 ESNs (76%) titrated medicine over the telephone. When starting a new drug 16 (55%) of ESNs did this over the telephone following a previous face to face discussion with the patient. The majority of ESNs 26 (90%) would recommend stopping a drug because of an adverse drug reaction such as an allergic rash over the telephone. All the ESN's would then document drug changes made via letter to the General Practitioner (GP) 25 (86%), in the patients hospital case notes 19 (66%) and 13 (45%) would copy the GP letter to the patient.
Fourteen (48%) of ESN's had audit processes in place and another 3 were intending to implement an audit into their prescribing practice in the near future.
It is essential that nurses keep updated particularly with regard to prescribing practice yet only 22 (76%) stated that they kept updated. This was achieved in a variety of ways through medical colleagues 15 (52%), meetings 20 (69%), peers 12 (41%), conferences 9 (31%), representatives 7 (24%), literature 9 (31%), study days 10 (34%) and in other ways 3 (10%).
Off label prescribing occurs when medications are prescribed outside of their licence. 15 This is likely to occur when prescribing anti-epilepsy medication for children. Off label prescribing was carried out independently by 8 (28%) of ESNs, supplementary prescribing using a CMP by 12 (41%) ESNs and/or through direct advise to the patients doctor 19 (53%). ESNs wrote a prescription for a new drug or recommended starting a new drug at least once a week whilst most ESNs titrated medication on a daily basis.
Discussion
This paper demonstrates that 18% of all UK epilepsy specialist nurses are prescribing. The majority of nurse prescribers in our study held an academic qualification at first degree or higher. The majority of respondents had been in post over 10 years demonstrating those ESNs undertaking the prescribing qualification are working at an advanced level. 16, 17 Enabling nurses to independently prescribe any licensed medicine in the UK improves the service patients receive by increasing patient access to medicines, and providing greater choice whilst ensuring patient safety. 10, 18 Our study identified that as well as prescribing anti-epilepsy drugs ESNs also recommended, and occasionally prescribed, folic acid, vitamin K, anti-depressants, anti-psychotics, the oral contraceptive pill, steroids and rescue medication. Although a diverse range of medications, all are relevant to the co-morbidities of people with epilepsy. Nurses working within a defined specialty are 'very familiar with, and knowledgeable about. . .' 19 the medications they use.
Disease specific telephone advice lines have increasingly become part of specialist nursing services offering quick and relevant access to expertise as well as improving continuity of care. 20 The Nursing
Midwifery Council (NMC) guidelines 15 state that in exceptional circumstances when a medication has been previously prescribed and where changes to dose are deemed necessary the use of a non face-to-face medium may be used, as long as the prescriber has prior knowledge of the patient/condition and has access to the patients' record. This rapid access to specialist advice ensures prompt and appropriate action leading to reduced demand on GP services, accident and emergency departments and neurology appointments and ensures patient satisfaction with services. 21 Nurses are accountable for ensuring their knowledge and skills are up-to-date in order to maintain competency and prescribe safely. The NMC. . . recommends that appraisal of continuing professional development needs should be conducted annually as part of the nurses personal development review using competency frameworks such as those developed by The National Prescribing Centre. 22 Audit should be undertaken to demonstrate prescribing safety. 22 Our study did not identify whether ESN used the competency framework or any other tool to monitor and evaluate their prescribing practice. Auditing of prescribing practice was conducted by a small number of ESN's. Most ESNs described being able to independently prescribe as reflecting positively on patient care. Twenty (69%) felt it improved patient care by Enabling a holistic approach Overcoming delayed access to medicines Responsive in a timely fashion Increased the nurses' autonomy
Conclusion
This study confirms that the majority of ESN prescribers hold higher academic qualifications and have worked in the field of epilepsy for years. The researchers believe the number of ESNs completing the prescribing course is likely to increase in future years.
The ability to undertake Independent and Supplementary prescribing has extended the role of ESNs in the UK and allows a holistic approach to epilepsy care improving access to services and the management of epilepsy.
There is a need for all nurse prescribers to ensure their ongoing competence to prescribe through continuing professional development. It should be a target for all ESN prescribers to update annually and to audit their prescribing practice to demonstrate prescribing safety. Further research is required to assess patient satisfaction with ESN prescribing practice.
